Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 122 entries
Sorted by: Best Match Show Resources per page
Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester disease.

American journal of hematology

Abeykoon JP, Lasho TL, Dasari S, Rech KL, Ranatunga WK, Manske MK, Tischer A, Ravindran A, Young JR, Tobin WO, Flanagan EP, Nowakowski KE, Ruan GJ, Shah MV, Bennani NN, Vassallo R, Ryu JH, Koster MJ, Davidge-Pitts CJ, Patnaik MM, Wu X, Witzig TE, Goyal G, Go RS.
PMID: 34978715
Am J Hematol. 2022 Jan 03; doi: 10.1002/ajh.26441. Epub 2022 Jan 03.

Erdheim-Chester disease (ECD) is a histiocytic neoplasm that predominantly harbors mitogen-activated protein kinase (MAPK) pathway variants. MAPK inhibitors typically are effective treatments, but mutations outside the MAPK pathway, such as CSF1R variants, may cause refractory ECD. We describe a...

Cite
Abeykoon JP, Lasho TL, Dasari S, et al. Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester disease. Am J Hematol. 2022;doi: 10.1002/ajh.26441.
Abeykoon, J. P., Lasho, T. L., Dasari, S., Rech, K. L., Ranatunga, W. K., Manske, M. K., Tischer, A., Ravindran, A., Young, J. R., Tobin, W. O., Flanagan, E. P., Nowakowski, K. E., Ruan, G. J., Shah, M. V., Bennani, N. N., Vassallo, R., Ryu, J. H., Koster, M. J., Davidge-Pitts, C. J., Patnaik, M. M., Wu, X., Witzig, T. E., Goyal, G., Go, R. S. (2022). Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester disease. American journal of hematology, . https://doi.org/10.1002/ajh.26441
Abeykoon, Jithma P, et al. "Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester disease." American journal of hematology vol. (2022). doi: https://doi.org/10.1002/ajh.26441
Abeykoon JP, Lasho TL, Dasari S, Rech KL, Ranatunga WK, Manske MK, Tischer A, Ravindran A, Young JR, Tobin WO, Flanagan EP, Nowakowski KE, Ruan GJ, Shah MV, Bennani NN, Vassallo R, Ryu JH, Koster MJ, Davidge-Pitts CJ, Patnaik MM, Wu X, Witzig TE, Goyal G, Go RS. Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester disease. Am J Hematol. 2022 Jan 03; doi: 10.1002/ajh.26441. Epub 2022 Jan 03. PMID: 34978715.
Copy Download .nbib Format: NLM
DiODe v2: Unambiguous and Fully-Automated Detection of Directional DBS Lead Orientation.

Brain sciences

Dembek TA, Hellerbach A, Jergas H, Eichner M, Wirths J, Dafsari HS, Barbe MT, Hunsche S, Visser-Vandewalle V, Treuer H.
PMID: 34827449
Brain Sci. 2021 Oct 31;11(11). doi: 10.3390/brainsci11111450.

Directional deep brain stimulation (DBS) leads are now widely used, but the orientation of directional leads needs to be taken into account when relating DBS to neuroanatomy. Methods that can reliably and unambiguously determine the orientation of directional DBS...

Cite
Dembek TA, Hellerbach A, Jergas H, et al. DiODe v2: Unambiguous and Fully-Automated Detection of Directional DBS Lead Orientation. Brain Sci. 2021;11(11)doi: 10.3390/brainsci11111450.
Dembek, T. A., Hellerbach, A., Jergas, H., Eichner, M., Wirths, J., Dafsari, H. S., Barbe, M. T., Hunsche, S., Visser-Vandewalle, V., & Treuer, H. (2021). DiODe v2: Unambiguous and Fully-Automated Detection of Directional DBS Lead Orientation. Brain sciences, 11(11), . https://doi.org/10.3390/brainsci11111450
Dembek, Till A, et al. "DiODe v2: Unambiguous and Fully-Automated Detection of Directional DBS Lead Orientation." Brain sciences vol. 11,11 (2021). doi: https://doi.org/10.3390/brainsci11111450
Dembek TA, Hellerbach A, Jergas H, Eichner M, Wirths J, Dafsari HS, Barbe MT, Hunsche S, Visser-Vandewalle V, Treuer H. DiODe v2: Unambiguous and Fully-Automated Detection of Directional DBS Lead Orientation. Brain Sci. 2021 Oct 31;11(11). doi: 10.3390/brainsci11111450. PMID: 34827449; PMCID: PMC8615850.
Copy Download .nbib Format: NLM
Targeted Detection of SARS-CoV-2 Nucleocapsid Sequence Variants by Mass Spectrometric Analysis of Tryptic Peptides.

Journal of proteome research

Maus A, Renuse S, Kemp J, Madugundu AK, Vanderboom PM, Blommel J, Jerde C, Dasari S, Kipp BR, Singh RJ, Grebe SK, Pandey A.
PMID: 34779632
J Proteome Res. 2022 Jan 07;21(1):142-150. doi: 10.1021/acs.jproteome.1c00613. Epub 2021 Nov 15.

COVID-19 vaccines are becoming more widely available, but accurate and rapid testing remains a crucial tool for slowing the spread of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus. Although the quantitative reverse transcription-polymerase chain reaction (qRT-PCR) remains the...

Cite
Maus A, Renuse S, Kemp J, et al. Targeted Detection of SARS-CoV-2 Nucleocapsid Sequence Variants by Mass Spectrometric Analysis of Tryptic Peptides. J Proteome Res. 2021;21(1):142-150doi: 10.1021/acs.jproteome.1c00613.
Maus, A., Renuse, S., Kemp, J., Madugundu, A. K., Vanderboom, P. M., Blommel, J., Jerde, C., Dasari, S., Kipp, B. R., Singh, R. J., Grebe, S. K., & Pandey, A. (2022). Targeted Detection of SARS-CoV-2 Nucleocapsid Sequence Variants by Mass Spectrometric Analysis of Tryptic Peptides. Journal of proteome research, 21(1), 142-150. https://doi.org/10.1021/acs.jproteome.1c00613
Maus, Anthony, et al. "Targeted Detection of SARS-CoV-2 Nucleocapsid Sequence Variants by Mass Spectrometric Analysis of Tryptic Peptides." Journal of proteome research vol. 21,1 (2022): 142-150. doi: https://doi.org/10.1021/acs.jproteome.1c00613
Maus A, Renuse S, Kemp J, Madugundu AK, Vanderboom PM, Blommel J, Jerde C, Dasari S, Kipp BR, Singh RJ, Grebe SK, Pandey A. Targeted Detection of SARS-CoV-2 Nucleocapsid Sequence Variants by Mass Spectrometric Analysis of Tryptic Peptides. J Proteome Res. 2022 Jan 07;21(1):142-150. doi: 10.1021/acs.jproteome.1c00613. Epub 2021 Nov 15. PMID: 34779632; PMCID: PMC8610007.
Copy Download .nbib Format: NLM
MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients.

Blood cancer journal

Mellors PW, Dasari S, Kohlhagen MC, Kourelis T, Go RS, Muchtar E, Gertz MA, Kumar SK, Buadi FK, Willrich MAV, Lust JA, Kapoor P, Lacy MQ, Dingli D, Hwa Y, Fonder A, Hobbs M, Hayman S, Warsame R, Leung NR, Lin Y, Gonsalves W, Siddiqui M, Kyle RA, Rajkumar SV, Murray DL, Dispenzieri A.
PMID: 33664227
Blood Cancer J. 2021 Mar 04;11(3):50. doi: 10.1038/s41408-021-00444-0.

Immunoenrichment-based matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS), termed MASS-FIX, offers several advantages over immunofixation for the detection and isotyping of serum monoclonal protein, including superior sensitivity and specificity, the ability to differentiate therapeutic monoclonal antibodies, and...

Cite
Mellors PW, Dasari S, Kohlhagen MC, et al. MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients. Blood Cancer J. 2021;11(3):50doi: 10.1038/s41408-021-00444-0.
Mellors, P. W., Dasari, S., Kohlhagen, M. C., Kourelis, T., Go, R. S., Muchtar, E., Gertz, M. A., Kumar, S. K., Buadi, F. K., Willrich, M. A. V., Lust, J. A., Kapoor, P., Lacy, M. Q., Dingli, D., Hwa, Y., Fonder, A., Hobbs, M., Hayman, S., Warsame, R., Leung, N. R., Lin, Y., Gonsalves, W., Siddiqui, M., Kyle, R. A., Rajkumar, S. V., Murray, D. L., & Dispenzieri, A. (2021). MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients. Blood cancer journal, 11(3), 50. https://doi.org/10.1038/s41408-021-00444-0
Mellors, Patrick W, et al. "MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients." Blood cancer journal vol. 11,3 (2021): 50. doi: https://doi.org/10.1038/s41408-021-00444-0
Mellors PW, Dasari S, Kohlhagen MC, Kourelis T, Go RS, Muchtar E, Gertz MA, Kumar SK, Buadi FK, Willrich MAV, Lust JA, Kapoor P, Lacy MQ, Dingli D, Hwa Y, Fonder A, Hobbs M, Hayman S, Warsame R, Leung NR, Lin Y, Gonsalves W, Siddiqui M, Kyle RA, Rajkumar SV, Murray DL, Dispenzieri A. MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients. Blood Cancer J. 2021 Mar 04;11(3):50. doi: 10.1038/s41408-021-00444-0. PMID: 33664227; PMCID: PMC7933343.
Copy Download .nbib Format: NLM
Thalamic Deep Brain Stimulation in Essential Tremor Plus Is as Effective as in Essential Tremor.

Brain sciences

Steffen JK, Jergas H, Petry-Schmelzer JN, Dembek TA, Thies T, Jost ST, Dafsari HS, Kessler J, Wirths J, Fink GR, Visser-Vandewalle V, Barbe MT.
PMID: 33322350
Brain Sci. 2020 Dec 11;10(12). doi: 10.3390/brainsci10120970.

The new essential tremor (ET) classification defined ET-plus (ET-p) as an ET subgroup with additional neurological signs besides action tremor. While deep brain stimulation (DBS) is effective in ET, there are no studies specifically addressing DBS effects in ET-p....

Cite
Steffen JK, Jergas H, Petry-Schmelzer JN, et al. Thalamic Deep Brain Stimulation in Essential Tremor Plus Is as Effective as in Essential Tremor. Brain Sci. 2020;10(12)doi: 10.3390/brainsci10120970.
Steffen, J. K., Jergas, H., Petry-Schmelzer, J. N., Dembek, T. A., Thies, T., Jost, S. T., Dafsari, H. S., Kessler, J., Wirths, J., Fink, G. R., Visser-Vandewalle, V., & Barbe, M. T. (2020). Thalamic Deep Brain Stimulation in Essential Tremor Plus Is as Effective as in Essential Tremor. Brain sciences, 10(12), . https://doi.org/10.3390/brainsci10120970
Steffen, Julia K, et al. "Thalamic Deep Brain Stimulation in Essential Tremor Plus Is as Effective as in Essential Tremor." Brain sciences vol. 10,12 (2020). doi: https://doi.org/10.3390/brainsci10120970
Steffen JK, Jergas H, Petry-Schmelzer JN, Dembek TA, Thies T, Jost ST, Dafsari HS, Kessler J, Wirths J, Fink GR, Visser-Vandewalle V, Barbe MT. Thalamic Deep Brain Stimulation in Essential Tremor Plus Is as Effective as in Essential Tremor. Brain Sci. 2020 Dec 11;10(12). doi: 10.3390/brainsci10120970. PMID: 33322350; PMCID: PMC7763605.
Copy Download .nbib Format: NLM
Impaired Muscle Mitochondrial Function in Familial Partial Lipodystrophy.

The Journal of clinical endocrinology and metabolism

Simha V, Lanza IR, Dasari S, Klaus KA, Le Brasseur N, Vuckovic I, Laurenti MC, Cobelli C, Port JD, Nair KS.
PMID: 34614176
J Clin Endocrinol Metab. 2021 Oct 06; doi: 10.1210/clinem/dgab725. Epub 2021 Oct 06.

BACKGROUND: Familial Partial Lipodystrophy (FPL), Dunnigan variety is characterized by skeletal muscle hypertrophy and insulin resistance besides fat loss from the extremities. The cause for the muscle hypertrophy, and its functional consequences is not known.OBJECTIVE: To compare muscle strength...

Cite
Simha V, Lanza IR, Dasari S, et al. Impaired Muscle Mitochondrial Function in Familial Partial Lipodystrophy. J Clin Endocrinol Metab. 2021;doi: 10.1210/clinem/dgab725.
Simha, V., Lanza, I. R., Dasari, S., Klaus, K. A., Le Brasseur, N., Vuckovic, I., Laurenti, M. C., Cobelli, C., Port, J. D., & Nair, K. S. (2021). Impaired Muscle Mitochondrial Function in Familial Partial Lipodystrophy. The Journal of clinical endocrinology and metabolism, . https://doi.org/10.1210/clinem/dgab725
Simha, Vinaya, et al. "Impaired Muscle Mitochondrial Function in Familial Partial Lipodystrophy." The Journal of clinical endocrinology and metabolism vol. (2021). doi: https://doi.org/10.1210/clinem/dgab725
Simha V, Lanza IR, Dasari S, Klaus KA, Le Brasseur N, Vuckovic I, Laurenti MC, Cobelli C, Port JD, Nair KS. Impaired Muscle Mitochondrial Function in Familial Partial Lipodystrophy. J Clin Endocrinol Metab. 2021 Oct 06; doi: 10.1210/clinem/dgab725. Epub 2021 Oct 06. PMID: 34614176.
Copy Download .nbib Format: NLM
Donor-Derived ALECT2 Amyloidosis and Recurrent Fibrillary Glomerulonephritis in a Transplant Allograft.

Kidney medicine

Nasr SH, Chavez O, Dasari S, Theis JD, Vrana JA, Fatima H, Fu L, Baliga RS, McPhail ED.
PMID: 34136788
Kidney Med. 2021 Feb 16;3(3):433-437. doi: 10.1016/j.xkme.2020.11.019. eCollection 2021.

The occurrence of renal amyloidosis and fibrillary glomerulonephritis in the same biopsy specimen is exceptional and poses a diagnostic challenge. We describe the case of a non-Hispanic White patient with end-stage kidney disease due to fibrillary glomerulonephritis who received...

Cite
Nasr SH, Chavez O, Dasari S, et al. Donor-Derived ALECT2 Amyloidosis and Recurrent Fibrillary Glomerulonephritis in a Transplant Allograft. Kidney Med. 2021;3(3):433-437doi: 10.1016/j.xkme.2020.11.019.
Nasr, S. H., Chavez, O., Dasari, S., Theis, J. D., Vrana, J. A., Fatima, H., Fu, L., Baliga, R. S., & McPhail, E. D. (2021). Donor-Derived ALECT2 Amyloidosis and Recurrent Fibrillary Glomerulonephritis in a Transplant Allograft. Kidney medicine, 3(3), 433-437. https://doi.org/10.1016/j.xkme.2020.11.019
Nasr, Samih H, et al. "Donor-Derived ALECT2 Amyloidosis and Recurrent Fibrillary Glomerulonephritis in a Transplant Allograft." Kidney medicine vol. 3,3 (2021): 433-437. doi: https://doi.org/10.1016/j.xkme.2020.11.019
Nasr SH, Chavez O, Dasari S, Theis JD, Vrana JA, Fatima H, Fu L, Baliga RS, McPhail ED. Donor-Derived ALECT2 Amyloidosis and Recurrent Fibrillary Glomerulonephritis in a Transplant Allograft. Kidney Med. 2021 Feb 16;3(3):433-437. doi: 10.1016/j.xkme.2020.11.019. eCollection 2021. PMID: 34136788; PMCID: PMC8178471.
Copy Download .nbib Format: NLM
Optical Microangiography and Progressive Retinal Nerve Fiber Layer Loss in Primary Open Angle Glaucoma.

American journal of ophthalmology

Rao HL, Dasari S, Puttaiah NK, Pradhan ZS, Moghimi S, Mansouri K, Webers CAB, Weinreb RN.
PMID: 34320375
Am J Ophthalmol. 2022 Jan;233:171-179. doi: 10.1016/j.ajo.2021.07.023. Epub 2021 Jul 25.

PURPOSE: To evaluate the association between optical microangiography (OMAG) measurements and progressive retinal nerve fiber layer (RNFL) loss in primary open angle glaucoma (POAG).DESIGN: Prospective case series.METHODS: Sixty-four eyes of 40 patients with POAG (108 quadrants) with mild to...

Cite
Rao HL, Dasari S, Puttaiah NK, et al. Optical Microangiography and Progressive Retinal Nerve Fiber Layer Loss in Primary Open Angle Glaucoma. Am J Ophthalmol. 2021;233:171-179doi: 10.1016/j.ajo.2021.07.023.
Rao, H. L., Dasari, S., Puttaiah, N. K., Pradhan, Z. S., Moghimi, S., Mansouri, K., Webers, C. A. B., & Weinreb, R. N. (2022). Optical Microangiography and Progressive Retinal Nerve Fiber Layer Loss in Primary Open Angle Glaucoma. American journal of ophthalmology, 233171-179. https://doi.org/10.1016/j.ajo.2021.07.023
Rao, Harsha L, et al. "Optical Microangiography and Progressive Retinal Nerve Fiber Layer Loss in Primary Open Angle Glaucoma." American journal of ophthalmology vol. 233 (2022): 171-179. doi: https://doi.org/10.1016/j.ajo.2021.07.023
Rao HL, Dasari S, Puttaiah NK, Pradhan ZS, Moghimi S, Mansouri K, Webers CAB, Weinreb RN. Optical Microangiography and Progressive Retinal Nerve Fiber Layer Loss in Primary Open Angle Glaucoma. Am J Ophthalmol. 2022 Jan;233:171-179. doi: 10.1016/j.ajo.2021.07.023. Epub 2021 Jul 25. PMID: 34320375; PMCID: PMC8678163.
Copy Download .nbib Format: NLM
Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease.

Journal of neurology, neurosurgery, and psychiatry

Sauerbier A, Loehrer P, Jost ST, Heil S, Petry-Schmelzer JN, Herberg J, Bachon P, Aloui S, Gronostay A, Klingelhoefer L, Baldermann JC, Huys D, Nimsky C, Barbe MT, Fink GR, Martinez-Martin P, Ray Chaudhuri K, Visser-Vandewalle V, Timmermann L, Weintraub D, Dafsari HS.
PMID: 34510000
J Neurol Neurosurg Psychiatry. 2021 Dec;92(12):1313-1318. doi: 10.1136/jnnp-2021-326131. Epub 2021 Sep 11.

BACKGROUND: The effects of subthalamic stimulation (subthalamic nucleus-deep brain stimulation, STN-DBS) on impulsive and compulsive behaviours (ICB) in Parkinson's disease (PD) are understudied.OBJECTIVE: To investigate clinical predictors of STN-DBS effects on ICB.METHODS: In this prospective, open-label, multicentre study in...

Cite
Sauerbier A, Loehrer P, Jost ST, et al. Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease. J Neurol Neurosurg Psychiatry. 2021;92(12):1313-1318doi: 10.1136/jnnp-2021-326131.
Sauerbier, A., Loehrer, P., Jost, S. T., Heil, S., Petry-Schmelzer, J. N., Herberg, J., Bachon, P., Aloui, S., Gronostay, A., Klingelhoefer, L., Baldermann, J. C., Huys, D., Nimsky, C., Barbe, M. T., Fink, G. R., Martinez-Martin, P., Ray Chaudhuri, K., Visser-Vandewalle, V., Timmermann, L., Weintraub, D., Dafsari, H. S. (2021). Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease. Journal of neurology, neurosurgery, and psychiatry, 92(12), 1313-1318. https://doi.org/10.1136/jnnp-2021-326131
Sauerbier, Anna, et al. "Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease." Journal of neurology, neurosurgery, and psychiatry vol. 92,12 (2021): 1313-1318. doi: https://doi.org/10.1136/jnnp-2021-326131
Sauerbier A, Loehrer P, Jost ST, Heil S, Petry-Schmelzer JN, Herberg J, Bachon P, Aloui S, Gronostay A, Klingelhoefer L, Baldermann JC, Huys D, Nimsky C, Barbe MT, Fink GR, Martinez-Martin P, Ray Chaudhuri K, Visser-Vandewalle V, Timmermann L, Weintraub D, Dafsari HS. Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease. J Neurol Neurosurg Psychiatry. 2021 Dec;92(12):1313-1318. doi: 10.1136/jnnp-2021-326131. Epub 2021 Sep 11. PMID: 34510000; PMCID: PMC8606469.
Copy Download .nbib Format: NLM
Erratum. TFAM Enhances Fat Oxidation and Attenuates High-Fat Diet-Induced Insulin Resistance in Skeletal Muscle. Diabetes 2019;68:1552-1564.

Diabetes

Koh JH, Johnson ML, Dasari S, LeBrasseur NK, Vuckovic I, Henderson GC, Cooper SA, Manjunatha S, Ruegsegger GN, Shulman GI, Lanza IR, Nair KS.
PMID: 32532806
Diabetes. 2020 Aug;69(8):1854. doi: 10.2337/db20-er08a. Epub 2020 Jun 12.

No abstract available.

Cite
Koh JH, Johnson ML, Dasari S, et al. Erratum. TFAM Enhances Fat Oxidation and Attenuates High-Fat Diet-Induced Insulin Resistance in Skeletal Muscle. Diabetes 2019;68:1552-1564. Diabetes. 2020;69(8):1854doi: 10.2337/db20-er08a.
Koh, J. H., Johnson, M. L., Dasari, S., LeBrasseur, N. K., Vuckovic, I., Henderson, G. C., Cooper, S. A., Manjunatha, S., Ruegsegger, G. N., Shulman, G. I., Lanza, I. R., & Nair, K. S. (2020). Erratum. TFAM Enhances Fat Oxidation and Attenuates High-Fat Diet-Induced Insulin Resistance in Skeletal Muscle. Diabetes 2019;68:1552-1564. Diabetes, 69(8), 1854. https://doi.org/10.2337/db20-er08a
Koh, Jin-Ho, et al. "Erratum. TFAM Enhances Fat Oxidation and Attenuates High-Fat Diet-Induced Insulin Resistance in Skeletal Muscle. Diabetes 2019;68:1552-1564." Diabetes vol. 69,8 (2020): 1854. doi: https://doi.org/10.2337/db20-er08a
Koh JH, Johnson ML, Dasari S, LeBrasseur NK, Vuckovic I, Henderson GC, Cooper SA, Manjunatha S, Ruegsegger GN, Shulman GI, Lanza IR, Nair KS. Erratum. TFAM Enhances Fat Oxidation and Attenuates High-Fat Diet-Induced Insulin Resistance in Skeletal Muscle. Diabetes 2019;68:1552-1564. Diabetes. 2020 Aug;69(8):1854. doi: 10.2337/db20-er08a. Epub 2020 Jun 12. PMID: 32532806; PMCID: PMC7519475.
Copy Download .nbib Format: NLM
Referenced scans improve the repeatability of optical coherence tomography angiography measurements in normal and glaucoma eyes.

The British journal of ophthalmology

Rao HL, Dasari S, Riyazuddin M, Lavanya R, P NK, Pradhan ZS, Moghimi S, Mansouri K, Webers CAB, Weinreb RN.
PMID: 32962991
Br J Ophthalmol. 2021 Nov;105(11):1542-1547. doi: 10.1136/bjophthalmol-2020-316480. Epub 2020 Sep 22.

AIM: To compare the repeatability of peripapillary perfusion density and flux index measurements on referenced and non-referenced optical microangiography (OMAG) scans in normal, glaucoma suspect and glaucoma eyes.METHODS: In a cross-sectional study, 48 eyes (33 subjects) underwent three repeat,...

Cite
Rao HL, Dasari S, Riyazuddin M, et al. Referenced scans improve the repeatability of optical coherence tomography angiography measurements in normal and glaucoma eyes. Br J Ophthalmol. 2020;105(11):1542-1547doi: 10.1136/bjophthalmol-2020-316480.
Rao, H. L., Dasari, S., Riyazuddin, M., Lavanya, R., P, N. K., Pradhan, Z. S., Moghimi, S., Mansouri, K., Webers, C. A. B., & Weinreb, R. N. (2021). Referenced scans improve the repeatability of optical coherence tomography angiography measurements in normal and glaucoma eyes. The British journal of ophthalmology, 105(11), 1542-1547. https://doi.org/10.1136/bjophthalmol-2020-316480
Rao, Harsha Laxmana, et al. "Referenced scans improve the repeatability of optical coherence tomography angiography measurements in normal and glaucoma eyes." The British journal of ophthalmology vol. 105,11 (2021): 1542-1547. doi: https://doi.org/10.1136/bjophthalmol-2020-316480
Rao HL, Dasari S, Riyazuddin M, Lavanya R, P NK, Pradhan ZS, Moghimi S, Mansouri K, Webers CAB, Weinreb RN. Referenced scans improve the repeatability of optical coherence tomography angiography measurements in normal and glaucoma eyes. Br J Ophthalmol. 2021 Nov;105(11):1542-1547. doi: 10.1136/bjophthalmol-2020-316480. Epub 2020 Sep 22. PMID: 32962991.
Copy Download .nbib Format: NLM
Somatostatin-derived amyloidosis: a novel type of amyloidosis associated with well-differentiated somatostatin-producing neuroendocrine tumours.

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Van Treeck BJ, Dasari S, Kurtin PJ, Theis JD, Nasr SH, Zhang L, Yasir S, Graham RP, McPhail ED, Said S.
PMID: 34541974
Amyloid. 2021 Sep 20;1-6. doi: 10.1080/13506129.2021.1979512. Epub 2021 Sep 20.

OBJECTIVE: To report the clinicopathologic and proteomic characteristics of a novel form of amyloidosis derived from the precursor protein somatostatin.MATERIALS AND METHODS: Cases were identified by searching the Mayo Clinic amyloid liquid chromatography and tandem mass spectrometry (LC-MS/MS) typing...

Cite
Van Treeck BJ, Dasari S, Kurtin PJ, et al. Somatostatin-derived amyloidosis: a novel type of amyloidosis associated with well-differentiated somatostatin-producing neuroendocrine tumours. Amyloid. 2021;1-6doi: 10.1080/13506129.2021.1979512.
Van Treeck, B. J., Dasari, S., Kurtin, P. J., Theis, J. D., Nasr, S. H., Zhang, L., Yasir, S., Graham, R. P., McPhail, E. D., & Said, S. (2021). Somatostatin-derived amyloidosis: a novel type of amyloidosis associated with well-differentiated somatostatin-producing neuroendocrine tumours. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 1-6. https://doi.org/10.1080/13506129.2021.1979512
Van Treeck, Benjamin J, et al. "Somatostatin-derived amyloidosis: a novel type of amyloidosis associated with well-differentiated somatostatin-producing neuroendocrine tumours." Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis vol. (2021): 1-6. doi: https://doi.org/10.1080/13506129.2021.1979512
Van Treeck BJ, Dasari S, Kurtin PJ, Theis JD, Nasr SH, Zhang L, Yasir S, Graham RP, McPhail ED, Said S. Somatostatin-derived amyloidosis: a novel type of amyloidosis associated with well-differentiated somatostatin-producing neuroendocrine tumours. Amyloid. 2021 Sep 20;1-6. doi: 10.1080/13506129.2021.1979512. Epub 2021 Sep 20. PMID: 34541974.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 122 entries